Protagonist Therapeutics Inc (PTGX)
28.93
+0.45
(+1.58%)
USD |
NASDAQ |
Mar 28, 16:00
28.97
+0.04
(+0.14%)
Pre-Market: 20:00
Protagonist Therapeutics Cash from Operations (TTM): -70.24M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -70.24M |
September 30, 2023 | -118.83M |
June 30, 2023 | -117.42M |
March 31, 2023 | -104.82M |
December 31, 2022 | -108.14M |
September 30, 2022 | -103.44M |
June 30, 2022 | -106.71M |
March 31, 2022 | -116.78M |
December 31, 2021 | -107.86M |
September 30, 2021 | -99.79M |
June 30, 2021 | -87.61M |
March 31, 2021 | -85.39M |
December 31, 2020 | -72.48M |
September 30, 2020 | -67.91M |
June 30, 2020 | -65.86M |
March 31, 2020 | -40.71M |
December 31, 2019 | -41.53M |
Date | Value |
---|---|
September 30, 2019 | -37.37M |
June 30, 2019 | -32.40M |
March 31, 2019 | -51.47M |
December 31, 2018 | -49.95M |
September 30, 2018 | -53.96M |
June 30, 2018 | -3.981M |
March 31, 2018 | -0.91M |
December 31, 2017 | 3.872M |
September 30, 2017 | 8.341M |
June 30, 2017 | -39.34M |
March 31, 2017 | -35.09M |
December 31, 2016 | -29.97M |
September 30, 2016 | -25.03M |
June 30, 2016 | -21.82M |
March 31, 2016 | -17.19M |
December 31, 2015 | -14.38M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-118.83M
Minimum
Sep 2023
-32.40M
Maximum
Jun 2019
-81.84M
Average
-86.50M
Median
Cash from Operations (TTM) Benchmarks
SELLAS Life Sciences Group Inc | -31.74M |
Arvinas Inc | -347.80M |
Akebia Therapeutics Inc | -23.38M |
Immuneering Corp | -48.97M |
Moderna Inc | -3.118B |